Better imaging methods to accurately resolve glioma margins may help improve resection and clinical outcomes for glioma patients. Currently, clinical imaging technologies cannot reliably visualize infiltrating glioma cells, leading to incomplete resections and tumor recurrence. Recently, Ji et al1 demonstrated improvements in the use of stimulated Raman scattering (SRS) microscopy in a label-free, automated fashion to accurately delineate tumor margins in ex vivo tissue specimens. . .
Full text is available to all readers.